Active	Status	Sponsor type	Region	Phase	Filter
8 Active 50 Inactive 58 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Adlyxin (lixisenatide) / Sanofi
2016-001758-17: Lixisenatide Arterial Stiffness Trial	Ongoing	4	120	Europe	Lixisenatide (Lyxumia), Suspension for injection in pre-filled pen, Lyxumia	King's College London, Guy's and St Thomas' NHS Foundation Trust, Sanofi Aventis Limited	Type 2 diabetes, Diabetes, Diseases [C] - Hormonal diseases [C19]